Posted by Michael Wonder on 06 Jul 2024
Submission of Nidlegy marketing authorisation application validated by EMA
4 July 2024 - The assessment period of the dossier by the authorities has started on 20 June.
The first marketing authorisation application of Nidleg for the treatment of locally advanced fully resectable melanoma was submitted on 3 June and validated by EMA on 20 June.
